44 Siglec-G Expression on Donor T Cells Controls Severity of Gvhd

Track: BMT Tandem "Scientific" Meeting
Friday, February 13, 2015, 10:30 AM-12:00 PM
Harbor Ballroom ABC (Manchester Grand Hyatt)
Tomomi Toubai, M.D., PhD , Internal Medicine - Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Corinne Rossi , University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Guoqing Hou, Ph.D , Internal Medicine - Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Katherine Oravecz-Wilson , Internal Medicine - Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Chen Liu , Department of Pathology, University of Florida College of Medicine, Gainesville, FL
Nathan Mathewson , Internal Medicine - Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Yaping Sun, Ph.D. , Internal Medicine - Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Julia Wu , Internal Medicine - Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Pang Zheng , Center for Cancer and Immunology Research, Children’s National Medical Center, Washington, DC, DC
Yang Liu , Center for Cancer and Immunology Research, Children’s National Medical Center, Washington, DC
Sung Won Choi, M.D. , Pediatric Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI
Pavan Reddy, MD , Internal Medicine - Hematology and Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Members of the sialic acid binding Ig–like lectin (Siglec) family, such as Siglec-G, have immunoreceptor tyrosine-based inhibitory motifs (ITIM) regions that negatively regulate innate immune activation induced by non-infectious damage-associated molecular patterns (DAMPs). The T-cell autonomous role of Siglec-G in modulating immunity is not known. In order to examine the role of Siglec-G on T-cells we utilized the well-established MHC disparate B6->BALB/c model of allogeneic BMT. BALB/c WT mice were lethally irradiated (850cGy) and transplanted on day 0 with 5x106 WT bone marrow from either syngeneic WT-BALB/c or allogeneic WT-B6 along with and 0.5x106 CD90+T cells from WT or Siglec-G-/- B6 animals. The allogeneic recipients receiving donor T cells from Siglec-G-/- animals showed significantly more severe GVHD and worse survival compared to allogeneic WT-B6 animals (p=0.01). This increased mortality was also associated with greater GVHD specific histopathology but similar levels of DAMPs such as HMGB1. Donor T cell analyses demonstrated significantly greater expansion of activated CD69+, Th1 (IFN-g+) and Th17 (IL-17A+) cells in the spleen and in the GVHD target organs, namely liver and gut (P<0.05). Enhanced GVHD mortality and severity was observed in multiple irradiated BMT models (MHC-matched multiple minor antigen mismatched C3H.sw->B6 and haploidentical B6->F1 models). We performed detailed phenotypic analysis of various T cell subsets in naïve Siglec-G-/- and WT B6 animals and found similar distribution of naïve, memory, effector and regulatory T cells suggesting that alteration in T-cell subsets in the donor T-cell inoculum was not the cause for increase in GVHD. Functional analyses of naïve Siglec-G-/- T cells, showed similar proliferation in vitro after stimulation with allogeneic DCs or CD3/CD28 antibody stimulation when compared to WT T cells. Furthermore Siglec-G-/- Tregs as well as WT Tregs were equally suppressive in repressing either WT or Siglec-G-/- naïve T-cells demonstrating that Siglec-G expression on Tregs is not critical for their suppressive function or on naïve T-cells to be regulated by Tregs. By contrast Siglec-G-/- T cells showed higher proliferation after TCR stimulation (CD3/CD28) only upon with addition of DAMP (HMGB-1) demonstrating that direct regulation of T-cell response to DAMP by Siglec-G regulates its TCR driven proliferative responses. Finally, in order to explore the Siglec-G +T cells interaction with its ligand in hosts, we next used CD24-/- BALB/c animals as hosts. CD24-/- animals also demonstrated enhanced GVHD mortality when compared to WT animals. Collectively, our data suggest, for the first time to our knowledge that Siglec-G mediated responses to DAMPs has T-cell autonomous effects and through its engagement with its ligand CD24 in the hosts is critical for mitigating GVHD.
Disclosures:
Nothing To Disclose